Produktportfolio (DE) 2020 | Page 5

ZUVERLÄSSIGE SENSITIVITÄT IN ALLEN SCHWANGERSCHAFTSWOCHEN
PATIENTEN SENSITIVITÄT
SPEZIFITÄT
ROM PLUS ES IFU 285 99 , 5 %
90 , 7 %
Herkömmliche Verfahren
THOMASINO , 2013 2 285 99 , 5 %
90 , 7 %
IGBINOSA , 2017 3
111 96 , 4 % 98 , 8 %
SENSITIVITÄT
SPEZIFITÄT
1
SENANAYAKE , 2013 95 98 , 9 % N / A
NITRAZINE 5 90-97 % 16-70 %
ROGERS , 2016 4
75 100 % 94 , 8 %
FERNING 5
51-98 % 70-88 %
ESPLIN , 2019 9 324 91 , 7 97 %
9
POOLING Subjektiv Subjektiv
1 . Senanayake HM . Actim™ PROM , AmniSure ® , and ROM + plus ® : Rupture of membrane kits tested on amniotic fluid from women at C-section : a comparative study . Sri Lanka Journal of Obstetrics and Gynaecology . 2013 ; 116-121 .
2 . Thomasino T , Levi C , Draper M , Neubert AG . Diagnosing rupture of membranes using combination monoclonal / polyclonal immunologic protein detection . J Reprod Med . 2013 ; 58 ( 5 – 6 ): 187 – 194 .
3 . Igbinosa , Irogue & A . Moore , Ferney & Johnson , Cheri & Block , Jon . ( 2017 ). Comparison of rapid immunoassays for rupture of fetal membranes . BMC Pregnancy and Childbirth . 17 . . 10.1186 / s12884-017-1311-y .
4 . Rogers LC , Scott L , Block JE . Accurate point-of-care detection of ruptured fetal membranes : improved diagnostic performance characteristics with a monoclonal / polyclonal immunoassay . Clin Med Insights Reprod Health . 2016 ; 10:15 – 8 .
5 . Caughey , et al . Rev Obstet Gynecol 2008 ; 1:11-22 . de Haan et al ., Am J Perinatol 1994 ; 11:46-50
6 . Esplin , et . al . Prospective evaluation of the efficacy of immunoassays in the diagnosis of rupture of the membranes . J Matern Fetal Neonatal Med . 2019 Jan 13:1-7 . doi : 10.1080 / 14767058.2018.1555809 . [ Epub ahead of print ]
5